III 

117TH CONGRESS 

2D SESSION S. RES. 523 

Designating February 28, 2022, as ‘‘Rare Disease Day’’. 

IN THE SENATE OF THE UNITED STATES 

FEBRUARY 17, 2022 

Mr. BROWN (for himself, Mr. BARRASSO, Ms. KLOBUCHAR, Mr. WHITEHOUSE, Mr. BOOKER, Mr. BLUMENTHAL, Mr. MARKEY, Mr. WICKER, 

Mr. SCOTT of South Carolina, and Mr. CASEY) submitted the following 

resolution; which was considered and agreed to 

RESOLUTION 

Designating February 28, 2022, as ‘‘Rare Disease Day’’. 

Whereas a rare disease or disorder is a disease or disorder 

that affects a small number of patients; 

Whereas, in the United States, a rare disease or disorder affects fewer than 200,000 individuals; 

Whereas, as of the date of the adoption of this resolution, 

more than 7,000 rare diseases or disorders affect approximately 1 in 10 individuals in the United States; 

Whereas children with rare diseases or disorders account for 

a significant portion of the population affected by rare 

diseases or disorders in the United States; 

Whereas many rare diseases and disorders are serious and 

life-threatening and lack effective treatments; 


kjohnson on DSK79L0C42PROD with BILLS
2 

•SRES 523 ATS 

Whereas, as a result of the enactment of the Orphan Drug 

Act (Public Law 97–414; 96 Stat. 2049), important advances have been made in the research and treatment of 

rare diseases and disorders; 

Whereas the Food and Drug Administration (FDA) has 

made strides in gathering patient perspectives to inform 

the drug review process as part of the Patient-Focused 

Drug Development program, an initiative that was reaffirmed under the FDA Reauthorization Act of 2017 

(Public Law 115–52; 131 Stat. 1005); 

Whereas, although the Food and Drug Administration has 

approved more than 1,000 orphan indications for drugs 

and biological products for the treatment of rare diseases 

and disorders, 95 percent of rare diseases do not have an 

FDA-approved treatment for their condition; 

Whereas limited treatment options and difficulty obtaining 

reimbursement for life-altering and lifesaving treatments 

can be challenging for individuals with rare diseases or 

disorders and their families; 

Whereas rare diseases and disorders include sickle cell anemia, spinal muscular atrophy, amyotrophic lateral sclerosis, thyroid eye disease, myotonic dystrophy, t-cell 

prolymphocytic leukemia, microtia, meatal atresia, and 

conductive deafness; 

Whereas individuals with rare diseases or disorders can experience difficulty in obtaining accurate diagnoses and finding physicians or treatment centers with expertise in 

their rare disease or disorder; 

Whereas the 116th Congress passed a 4-year extension of the 

Rare Pediatric Disease Priority Review Voucher program 

under section 529(b) of the Federal Food, Drug, and 


kjohnson on DSK79L0C42PROD with BILLS
3 

•SRES 523 ATS 

Cosmetic Act (21 U.S.C. 360ff(b)) as part of the Consolidated Appropriations Act, 2021 (Public Law 116–260; 

134 Stat. 1182), providing an incentive for the development of therapies for children with rare diseases; 

Whereas the 116th Congress passed the Advancing Care for 

Exceptional Kids Act (Public Law 116–16; 133 Stat. 

852), improving access to coordinated, patient-centered 

health care for children with complex and rare medical 

conditions in Medicaid; 

Whereas the Food and Drug Administration and the National 

Institutes of Health support research on the treatment of 

rare diseases and disorders; 

Whereas 2022 marks the 39th anniversary of the enactment 

of the Orphan Drug Act (Public Law 97–414; 96 Stat. 

2049); 

Whereas Rare Disease Day is observed each year on the last 

day of February; 

Whereas Rare Disease Day is a global event that was first 

observed in the United States on February 28, 2009, and 

was observed in more than 100 countries in 2021; and 

Whereas Rare Disease Day is expected to be observed globally for years to come, providing hope and information 

for rare disease and disorder patients around the world: 

Now, therefore, be it 

1 Resolved, That the Senate— 

2 (1) designates February 28, 2022, as ‘‘Rare 

3 Disease Day’’; and 

4 (2) recognizes the importance of, with respect 

5 to rare diseases and disorders— 


kjohnson on DSK79L0C42PROD with BILLS
4 

•SRES 523 ATS 

1 (A) improving awareness; 

2 (B) encouraging accurate and early diag3 nosis; and 

4 (C) supporting national and global efforts 

5 to develop effective treatments, diagnostics, and 

6 cures. 

Æ 


kjohnson on DSK79L0C42PROD with BILLS